Biden Administration Send Less than Half the Lifesaving Antibody Treatment Needed to Florida

The Biden administration this week began to cut the distribution of monoclonal antibodies to red states, such as Florida and Alabama, contending those states, including Texas, Mississippi, Tennessee, Georgia, and Louisiana, are comprising too big a share of the supply in recent weeks — 70 percent.
“HHS will determine the amount of product each state and territory receives on a weekly basis,” a spokesman for the U.S. Department of Health and Human Services (HHS) said.

https://media.breitbart.com/media/2...a-governor-ron-desantis-it-e1631565102381.jpg
As a result of the Biden administration’s moves, the feds delivered less than half the needed doses to the Sunshine State this week. According to CBS12, they sent 30,950 doses “according to numbers from the governor’s office and confirmed by the Department of Health.” But normally, the state needs about 72,000 doses a week to meet the needs.

https://media.breitbart.com/media/2021/09/AP_21238618525932-e1631814926985.jpg

“If they will not help, if those governors won’t help us beat the pandemic, I’ll use my power as president to get them out of the way,” he vowed.

Folks ... I understand we have a thread on the virus..... This is pure political spite. People will die because of this ... Will Democrats be held accountable.? ... Look to Cuomo and the nursing home scandal..... for the answer..

Ron DeSantis Was Right about Monoclonal-Antibody Therapy​

wo months ago, Governor Ron DeSantis of Florida was being roundly castigated for promoting the use of Regeneron’s monoclonal-antibody treatment as part of his state’s efforts to fight COVID-19. Desperate to find something sinister in the push, DeSantis’s critics threw out every charge they could dream up. At first, the line was that Regeneron’s treatment didn’t work. Then, it was that Regeneron’s treatment worked fine, but represented a dangerous distraction from the vaccine. And, finally, it was that Regeneron’s treatment was part of a corrupt plot to enrich DeSantis’s donors.
Florida’s governor was blasted by progressives for promoting Regeneron’s COVID treatment. Now, demand is so great the Biden administration is rationing it.
Today, we learn from the Washington Post that, actually, none of that was the problem. Instead, DeSantis’s sin is that he has been relying upon monoclonal-antibody treatment too much, and that this is unfair to other states that now need it.

Florida’s DeSantis Responds to Biden Limiting Florida COVID Therapeutics – Announces Monoclonal Antibody Purchases Directly From Glaxo Smith Kline​

Florida's DeSantis Responds to Biden Limiting Florida COVID Therapeutics - Announces Monoclonal Antibody Purchases Directly From Glaxo Smith Kline - The Last Refuge

During a press conference earlier today, Governor DeSantis outlined the issues Florida is facing after the Biden administration instructed the federal offices of HHS to punish the successful therapy and recovery efforts of the sunshine state healthcare system. DeSantis outlines the purchase agreement that Biden intentionally violated and also the issues created by the federal government now blocking direct purchasing of treatment from the manufacturer.

Florida's DeSantis Responds to Biden Limiting Florida COVID Therapeutics - Announces Monoclonal Antibody Purchases Directly From Glaxo Smith Kline - The Last Refuge
Additionally, DeSantis noted he has held meetings with ¹GlaxoSmithKline (GSK) to purchase mAb shipments directly from the second source manufacturer in order to work around the roadblocks being presented by the Biden administration. DeSantis reaffirmed his commitment to stand in the way, and not allow Joe Biden to kill Americans just because he doesn’t like their politics.
Florida's DeSantis Responds to Biden Limiting Florida COVID Therapeutics - Announces Monoclonal Antibody Purchases Directly From Glaxo Smith Kline - The Last Refuge
Florida's DeSantis Responds to Biden Limiting Florida COVID Therapeutics - Announces Monoclonal Antibody Purchases Directly From Glaxo Smith Kline - The Last Refuge